David Hellerstein
Professor of Clinical Psychiatry at Columbia University Irving Medical Center; Research Psychiatrist at the New York State Psychiatric Institute; Director of the Depression Evaluation Service
Key Impact
He is a principal investigator on psilocybin studies for treatment-resistant depression and related psychiatric conditions, helping establish the clinical evidence base for psychedelic-assisted therapy.
Background & Research
David J. Hellerstein, MD, is a research psychiatrist at the New York State Psychiatric Institute and Professor of Clinical Psychiatry at Columbia University Irving Medical Center. He directs Columbia’s Depression Evaluation Service, and his work focuses on mood and anxiety disorders, especially treatment-resistant depression. Since 2019, his group has also taken a leadership role in psychedelic medication studies, including psilocybin for depression and other disorders.
Collaboration Network
26 collaborators· click a node to visit their profile
Full network →